39427196|t|Compromised endothelial Wnt/beta-catenin signaling mediates the blood-brain barrier disruption and leads to neuroinflammation in endotoxemia.
39427196|a|The blood-brain barrier (BBB) is a critical interface that maintains the central nervous system homeostasis by controlling the exchange of substances between the blood and the brain. Disruption of the BBB plays a vital role in the development of neuroinflammation and neurological dysfunction in sepsis, but the mechanisms by which the BBB becomes disrupted during sepsis are not well understood. Here, we induced endotoxemia, a major type of sepsis, in mice by intraperitoneal injection of lipopolysaccharide (LPS). LPS acutely increased BBB permeability, activated microglia, and heightened inflammatory responses in brain endothelium and parenchyma. Concurrently, LPS or proinflammatory cytokines activated the NF-kappaB pathway, inhibiting Wnt/beta-catenin signaling in brain endothelial cells in vitro and in vivo. Cell culture study revealed that NF-kappaB p65 directly interacted with beta-catenin to suppress Wnt/beta-catenin signaling. Pharmacological NF-kappaB pathway inhibition restored brain endothelial Wnt/beta-catenin signaling activity and mitigated BBB disruption and neuroinflammation in septic mice. Furthermore, genetic or pharmacological activation of brain endothelial Wnt/beta-catenin signaling substantially alleviated LPS-induced BBB leakage and neuroinflammation, while endothelial conditional ablation of the Wnt7a/7b co-receptor Gpr124 exacerbated the BBB leakage caused by LPS. Mechanistically, Wnt/beta-catenin signaling activation rectified the reduced expression levels of tight junction protein ZO-1 and transcytosis suppressor Mfsd2a in brain endothelial cells of mice with endotoxemia, inhibiting both paracellular and transcellular permeability of the BBB. Our findings demonstrate that endotoxemia-associated systemic inflammation decreases endothelial Wnt/beta-catenin signaling through activating NF-kappaB pathway, resulting in acute BBB disruption and neuroinflammation. Targeting the endothelial Wnt/beta-catenin signaling may offer a promising therapeutic strategy for preserving BBB integrity and treating neurological dysfunction in sepsis.
39427196	28	40	beta-catenin	Gene	1499
39427196	84	94	disruption	Disease	MESH:D019958
39427196	108	125	neuroinflammation	Disease	MESH:D000090862
39427196	129	140	endotoxemia	Disease	MESH:D019446
39427196	325	335	Disruption	Disease	MESH:D019958
39427196	388	405	neuroinflammation	Disease	MESH:D000090862
39427196	410	434	neurological dysfunction	Disease	MESH:D009461
39427196	438	444	sepsis	Disease	MESH:D018805
39427196	507	513	sepsis	Disease	MESH:D018805
39427196	556	567	endotoxemia	Disease	MESH:D019446
39427196	585	591	sepsis	Disease	MESH:D018805
39427196	596	600	mice	Species	10090
39427196	633	651	lipopolysaccharide	Chemical	MESH:D008070
39427196	653	656	LPS	Chemical	MESH:D008070
39427196	659	662	LPS	Chemical	MESH:D008070
39427196	735	747	inflammatory	Disease	MESH:D007249
39427196	809	812	LPS	Chemical	MESH:D008070
39427196	856	865	NF-kappaB	Gene	4790
39427196	890	902	beta-catenin	Gene	1499
39427196	995	1008	NF-kappaB p65	Gene	5970
39427196	1034	1046	beta-catenin	Gene	1499
39427196	1063	1075	beta-catenin	Gene	1499
39427196	1103	1112	NF-kappaB	Gene	4790
39427196	1163	1175	beta-catenin	Gene	1499
39427196	1213	1223	disruption	Disease	MESH:D019958
39427196	1228	1245	neuroinflammation	Disease	MESH:D000090862
39427196	1256	1260	mice	Species	10090
39427196	1338	1350	beta-catenin	Gene	1499
39427196	1386	1389	LPS	Chemical	MESH:D008070
39427196	1414	1431	neuroinflammation	Disease	MESH:D000090862
39427196	1500	1506	Gpr124	Gene	25960
39427196	1545	1548	LPS	Chemical	MESH:D008070
39427196	1571	1583	beta-catenin	Gene	1499
39427196	1671	1675	ZO-1	Gene	7082
39427196	1704	1710	Mfsd2a	Gene	84879
39427196	1741	1745	mice	Species	10090
39427196	1751	1762	endotoxemia	Disease	MESH:D019446
39427196	1866	1877	endotoxemia	Disease	MESH:D019446
39427196	1898	1910	inflammation	Disease	MESH:D007249
39427196	1937	1949	beta-catenin	Gene	1499
39427196	1979	1988	NF-kappaB	Gene	4790
39427196	2021	2031	disruption	Disease	MESH:D019958
39427196	2036	2053	neuroinflammation	Disease	MESH:D000090862
39427196	2085	2097	beta-catenin	Gene	1499
39427196	2193	2217	neurological dysfunction	Disease	MESH:D009461
39427196	2221	2227	sepsis	Disease	MESH:D018805
39427196	Negative_Correlation	MESH:D008070	1499
39427196	Association	MESH:D019958	1499
39427196	Association	MESH:D007249	4790
39427196	Negative_Correlation	MESH:D019446	7082
39427196	Association	MESH:D019446	84879
39427196	Association	MESH:D007249	1499
39427196	Association	MESH:D019446	4790
39427196	Association	1499	4790
39427196	Positive_Correlation	MESH:D008070	MESH:D000090862
39427196	Association	MESH:D008070	25960
39427196	Association	MESH:D000090862	4790
39427196	Association	MESH:D019446	1499
39427196	Positive_Correlation	MESH:D008070	MESH:D007249
39427196	Positive_Correlation	MESH:D008070	MESH:D019446
39427196	Association	1499	5970
39427196	Association	MESH:D000090862	1499
39427196	Association	MESH:D009461	1499
39427196	Positive_Correlation	MESH:D008070	4790
39427196	Positive_Correlation	1499	84879
39427196	Positive_Correlation	1499	7082
39427196	Association	MESH:D019958	4790

